Skip to main content
Premium Trial:

Request an Annual Quote

DuPont to Use Precision’s Nuclease Editing Technology in Crop Development

NEW YORK (GenomeWeb News) – DuPont has struck a collaboration agreement giving it rights to use Precision Biosciences’ Directed Nuclease Editor technology in its agricultural engineering programs, DuPont said today.
DuPont business Pioneer Hi-Bred plans to use the DNE technology to manipulate genes that can help speed development in corn, soybeans, and other agricultural crops.
Dupont said its scientists specifically plan to use the technology “to insert, remove and stack multiple traits at pre-selected sites in the plant genome, shortening the time it takes to bring new, high-value products to market.”
Precision’s DNE technology allows researchers to develop homing endonucleases that can target site-specific DNA breaks, and to use those to make specific modifications through inserting, removing, or regulating “virtually any gene.”
DuPont VP of Crop Genetics Research and Development William Niebur said that the DNE technology would enable the firm to “efficiently develop and rapidly deploy improved traits such as drought resistance, pest resistance and increased yield into the Pioneer lineup."
Financial terms of the agreement were not released.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.